Similar Stocks · Benchmarked Analysis · Peer Group

Peer Group Analysis

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Biotechnology Average - - - - - - 13,389.56 850.07 213.04 -130.41 35.80 0.00 20.2975 -0.47 -1.1525 -25.2645 -0.10 -0.08 7.5351 - -
Maximum - - - - - - 457,476.00 65,349.00 25,407.00 99,050.00 5,305.00 0.01 1,336.3467 6.70 3.0051 85.3485 0.38 8.35 61.5621 - -
Minimum - - - - - - 0.00 0.00 -1,175.00 -56,335.00 -1,185.00 0.00 -164.8536 -8.99 -101.7758 -1,444.7800 -1.56 -12.64 0.0007 - -
Akero Therapeutics, Inc. AKRO 29.76 -1.21 -3.91% 579 vs. 521 2,066.00 0.00 -53.00 -35.00 -627.00 -0.9000 -6.6902 0.0000 0.0000 0.0000 -0.0630 -0.0585 29.8643 69.00
Blueprint Medicines Corporation BPMC 95.65 -1.23 -1.27% 449 vs. 602 6,076.00 96.00 89.00 -102.00 -2,250.00 1.4500 16.6530 0.0000 0.9168 0.9274 0.2869 0.0858 3.4266 63.00
United Therapeutics Corporation UTHR 386.27 -14.18 -3.54% 252 vs. 392 17,244.00 677.00 306.00 338.00 6,333.00 6.5200 8.7477 0.0000 0.8924 0.4524 0.0574 0.0472 3.5035 44.00
Nuvalent, Inc. NUVL 90.18 -0.16 -0.18% 438 vs. 517 6,294.00 0.00 -44.00 -36.00 -330.00 -0.6900 -27.7942 0.0000 0.0000 0.0000 -0.0659 -0.0628 20.6970 69.00
Incyte Corporation INCY 77.73 -2.75 -3.42% 1,652 vs. 1,865 14,974.00 880.00 169.00 209.00 329.00 0.7600 18.7480 0.0000 0.9308 0.1925 0.0314 0.0238 3.2913 192.00
Alnylam Pharmaceuticals, Inc. ALNY 257.91 -6.69 -2.53% 603 vs. 824 33,265.00 494.00 -65.00 -94.00 -7,075.00 -0.5200 -73.3326 0.0000 0.8665 -0.1334 0.3007 -0.0172 2.8593 128.00
Vaxcyte, Inc. PCVX 92.68 -3.95 -4.09% 4,303 vs. 1,030 11,551.00 0.00 -95.00 -171.00 -1,019.00 -0.8500 -19.6094 0.0000 0.0000 0.0000 -0.0479 -0.0454 17.2498 124.00
Ultragenyx Pharmaceutical Inc. RARE 47.64 -1.07 -2.20% 559 vs. 719 4,399.00 108.00 -170.00 -203.00 -3,558.00 -2.0300 -5.7986 0.0000 0.7576 -1.5683 -1.2169 -0.1306 2.1127 92.00
Apellis Pharmaceuticals, Inc. APLS 28.06 -0.19 -0.67% 4,557 vs. 2,426 3,490.00 172.00 -66.00 -133.00 -2,903.00 -0.5400 -27.6326 0.0000 0.8802 -0.3855 -0.2491 -0.0798 2.7985 124.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for UTHR and its peers to uncover potential buy and sell opportunities.